News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Mendelsohn Michael
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/22/2022 |
4
| Mendelsohn Michael (Director) has filed a Form 4 on Foghorn Therapeutics Inc.|
Txns:
| Granted 16,000 options to buy
@ $13.81, valued at
$221k
|
|
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/14/2021 |
4
| Mendelsohn Michael (Director) has filed a Form 4 on Foghorn Therapeutics Inc.|
Txns:
| Granted 12,530 options to buy
@ $9.4, valued at
$117.8k
|
|
| 06/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/22/2020 |
3
| Mendelsohn Michael (Director) has filed a Form 3 on Foghorn Therapeutics Inc. |
| 06/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2019 |
4
| Mendelsohn Michael (Director) has filed a Form 4 on Cyclerion Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $13.95, valued at
$139.5k
|
|
| 04/03/2019 |
4
| Mendelsohn Michael (Director) has filed a Form 4 on Cyclerion Therapeutics, Inc.|
Txns:
| Granted 2,421 shares
@ $0 |
|
| 04/03/2019 |
3
| Mendelsohn Michael (Director) has filed a Form 3 on Cyclerion Therapeutics, Inc. |
| 01/05/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/03/2014 |
4
| Mendelsohn Michael (Director) has filed a Form 4 on Regado Biosciences Inc|
Txns:
| Granted 4,820 options to buy
@ $4.77, valued at
$23k
|
|
| 11/06/2013 |
3
| Mendelsohn Michael (Director) has filed a Form 3 on Regado Biosciences Inc |
|
|